What the company does
3SBio Inc., an investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People's Republic of China, the United States, and internationally. The company offers TPIAO bio-pharmaceutical drug for the treatment of chemotherapy-induced thrombocytopenia, immune thrombocytopenia, pediatric ITP, and chronic liver disease-related thrombocytopenia. It also provides EPIAO for indications, such as the treatment of anemia associated with chronic kidney disease, chemotherapy-induced anemia, and the reduction of allogeneic blood transfusion in surgery patients; and Yisaipu, a TNF-a inhibitor product for rheumatoid arthritis, ankylosing spondylitis, and psoriasis indications. In addition, the …
What the weekly tape is saying
1530 closed the latest completed week at 16.57 HKD. The 4-week return is -17.1% and the 12-week return is -25.0%. Trend Signal is inactive, Market Dynamics is -0.72. Setup signature: Risk-first tape with a 12/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 23.63 HKD
- Vs Trend Line
- -29.9%
- Fair Value
- 13.55 HKD
- Vs Fair Value
- 22.3%
- 52W High
- 36.80 HKD
- 52W Low
- 14.81 HKD
- Drawdown
- -55.0%
- Range Position
- 8.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 26
- 52W Active Breadth
- 50.0%
- Sector Scope
- HK Healthcare
- Sector Rank
- 26 of 257
- Sector Percentile
- 90.2%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
HK Healthcare
- Tracked Peers
- 100
- 4W Rank
- 71 of 100
- Avg 1W
- -1.3%
- Avg 4W
- -12.8%
- Trend Breadth
- 6.0%
- Positive MD
- 10.0%
HK Biotechnology
- Tracked Peers
- 76
- 4W Rank
- 34 of 76
- Avg 1W
- -1.6%
- Avg 4W
- -17.5%
- Trend Breadth
- 3.9%
- Positive RS
- 5.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.72
- 4W MD Change
- -1731.1%
- Relative Strength
- -33.74
- 4W RS Change
- -35.8%
- Expectation
- Negative
- Probability
- 42.38%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 170.5M
- 13W Average
- 160.3M
- 52W Average
- 162.1M
- Vs 13W
- 1.1x
- Vs 52W
- 1.1x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 8.0%
- 52W Volatility
- 8.9%
- Upside Weeks
- 20
- Downside Weeks
- 32
- Downside Breadth
- 61.5%
- Avg Gain / Loss
- 9.1% / -6.1%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- HKG
- Country
- HK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- HKD
- Market Cap
- 46.3B
Opportunity signals
- Price is above Fair Value, showing premium demand versus the model.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 16.57 HKD | 5.7% | 23.63 HKD | 13.55 HKD | -0.72 | -33.74 | 170.5M | Off |
| 5 Jun 2026 | 15.68 HKD | -15.2% | 24.22 HKD | 13.49 HKD | -0.56 | -38.26 | 238.1M | Off |
| 29 May 2026 | 18.50 HKD | -3.8% | 24.66 HKD | 13.43 HKD | -0.40 | -28.08 | 160.7M | Off |
| 22 May 2026 | 19.23 HKD | -3.8% | 25.07 HKD | 13.36 HKD | -0.21 | -26.57 | 110.3M | Off |
| 15 May 2026 | 19.99 HKD | -10.4% | 25.36 HKD | 13.29 HKD | 0.04 | -24.85 | 126.7M | Off |
| 8 May 2026 | 22.32 HKD | -3.5% | 25.64 HKD | 13.21 HKD | 0.31 | -17.11 | 99.4M | Off |
| 1 May 2026 | 23.14 HKD | 1.7% | 25.83 HKD | 13.11 HKD | 0.30 | -11.47 | 102.1M | Off |
| 24 Apr 2026 | 22.76 HKD | -9.9% | 26.07 HKD | 13.01 HKD | 0.43 | -13.09 | 219.7M | Off |
| 17 Apr 2026 | 25.26 HKD | 10.0% | 26.29 HKD | 12.91 HKD | 0.23 | -3.69 | 227.7M | Off |
| 10 Apr 2026 | 22.96 HKD | -9.5% | 26.46 HKD | 12.79 HKD | -0.31 | -10.85 | 133.1M | Off |
| 3 Apr 2026 | 25.38 HKD | 5.8% | 26.78 HKD | 12.70 HKD | -0.70 | 2.18 | 242.1M | Off |
| 27 Mar 2026 | 23.98 HKD | 8.5% | 27.12 HKD | 12.58 HKD | -1.05 | -1.98 | 129.1M | Off |
| 20 Mar 2026 | 22.10 HKD | 5.9% | 27.29 HKD | 12.48 HKD | -1.35 | -10.05 | 124.5M | Off |
| 13 Mar 2026 | 20.86 HKD | -3.4% | 27.59 HKD | 12.38 HKD | -1.45 | -14.98 | 139.0M | Off |